Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (34)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Wu, J.
Right arrow Articles by Wong, B. C. Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wu, J.
Right arrow Articles by Wong, B. C. Y.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis, Vol. 24, No. 2, 243-247, February 2003
© 2003 Oxford University Press


CANCER BIOLOGY

15-Lipoxygenase-1 mediates cyclooxygenase-2 inhibitor-induced apoptosis in gastric cancer

Jing Wu1,3, Harry Hua Xiang Xia1, Shui Ping Tu1, Dai Ming Fan3, Marie Chia Mi Lin2, Hsiang Fu Kung2, Shiu Kum Lam1 and Benjamin Chun Yu Wong1,4

1 Department of Medicine and
2 Institute of Molecular Biology, University of Hong Kong, Hong Kong and
3 Institute of Digestive Disease, Xijing Hospital, Fourth Military Medical University, Xian, P.R. China

It has been found that expression of 15-lipoxygenase-1 (15-LOX-1) and its main product, 13-S-hydroxyoctadecadienoic acid (13-S-HODE), are decreased in human colorectal and esophageal cancers and that non-steroidal anti-inflammatory drugs (NSAIDs) can therapeutically induce 15-LOX-1 expression to trigger apoptosis in those cancer cells. We found that a specific cyclooxygenase-2 (COX-2) inhibitor SC-236 similarly induced apoptosis in gastric cancer cells. In the present study, we tested whether SC-236 induced apoptosis through up-regulation of 15-LOX-1 in gastric cancer. We found that: (i) SC-236 inhibited growth of gastric cancer cells mainly by inducing apoptosis; (ii) SC-236 induced 15-LOX-1 expression and increased endogenous 13-S-HODE product, instead of 15-S-HETE during apoptosis; (iii) SC-236 did not affect expression of COX-1, COX-2, 5-LOX and 12-LOX; and (iv) 15-LOX-1 inhibition suppressed SC-236 induced apoptosis. These findings demonstrated that SC-236 induced apoptosis in gastric cancer cells via up-regulation of 15-LOX-1, and 13-S-HODE. These are potential and new targets for prevention and treatment of gastric cancer.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
X. Zuo, J. S. Morris, and I. Shureiqi
Chromatin Modification Requirements for 15-Lipoxygenase-1 Transcriptional Reactivation in Colon Cancer Cells
J. Biol. Chem., November 14, 2008; 283(46): 31341 - 31347.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
X. Zuo, L. Shen, J.-P. Issa, O. Moy, J. S. Morris, S. M. Lippman, and I. Shureiqi
15-Lipoxygenase-1 transcriptional silencing by DNA methyltransferase-1 independently of DNA methylation
FASEB J, June 1, 2008; 22(6): 1981 - 1992.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
K. Kuriki, K. Wakai, K. Matsuo, A. Hiraki, T. Suzuki, Y. Yamamura, K. Yamao, T. Nakamura, M. Tatematsu, and K. Tajima
Gastric Cancer Risk and Erythrocyte Composition of Docosahexaenoic Acid with Anti-inflammatory Effects
Cancer Epidemiol. Biomarkers Prev., November 1, 2007; 16(11): 2406 - 2415.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
X-X He, J Yang, Y-W Ding, W Liu, Q-Y Shen, and H H-X Xia
Increased epithelial and serum expression of macrophage migration inhibitory factor (MIF) in gastric cancer: potential role of MIF in gastric carcinogenesis
Gut, June 1, 2006; 55(6): 797 - 802.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. M. Lippman and J. J. Lee
Reducing the "Risk" of Chemoprevention: Defining and Targeting High Risk--2005 AACR Cancer Research and Prevention Foundation Award Lecture.
Cancer Res., March 15, 2006; 66(6): 2893 - 2903.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
I. Shureiqi, Y. Wu, D. Chen, X. L. Yang, B. Guan, J. S. Morris, P. Yang, R. A. Newman, R. Broaddus, S. R. Hamilton, et al.
The Critical Role of 15-Lipoxygenase-1 in Colorectal Epithelial Cell Terminal Differentiation and Tumorigenesis
Cancer Res., December 15, 2005; 65(24): 11486 - 11492.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
L. C. Hsi, X. Xi, Y. Wu, and S. M. Lippman
The methyltransferase inhibitor 5-aza-2-deoxycytidine induces apoptosis via induction of 15-lipoxygenase-1 in colorectal cancer cells
Mol. Cancer Ther., November 1, 2005; 4(11): 1740 - 1746.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
J.-S. Kim, S. J. Baek, F. G. Bottone Jr., T. Sali, and T. E. Eling
Overexpression of 15-Lipoxygenase-1 Induces Growth Arrest through Phosphorylation of p53 in Human Colorectal Cancer Cells
Mol. Cancer Res., September 1, 2005; 3(9): 511 - 517.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. I. Patel, K. Subbaramaiah, B. Du, M. Chang, P. Yang, R. A. Newman, C. Cordon-Cardo, H. T. Thaler, and A. J. Dannenberg
Celecoxib Inhibits Prostate Cancer Growth: Evidence of a Cyclooxygenase-2-Independent Mechanism
Clin. Cancer Res., March 1, 2005; 11(5): 1999 - 2007.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
N. Liu, F. Bi, Y. Pan, L. Sun, Y. Xue, Y. Shi, X. Yao, Y. Zheng, and D. Fan
Reversal of the Malignant Phenotype of Gastric Cancer Cells by Inhibition of RhoA Expression and Activity
Clin. Cancer Res., September 15, 2004; 10(18): 6239 - 6247.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.